Deciphera Pharmaceuticals (DCPH) Tops Q1 EPS by 10c

May 4, 2022 7:15 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q1 EPS of ($0.80), $0.10 better than the analyst estimate of ($0.90). Revenue for the quarter came in at $29.2 million versus the consensus estimate of $26.43 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities